Products Categories
CAS No.: | 1115-63-5 | ||
---|---|---|---|
Name: | L-ASPARTIC ACID POTASSIUM SALT | ||
Molecular Structure: | |||
Formula: | C4H7 N O4 . K | ||
Molecular Weight: | 171.194 | ||
Synonyms: | Asparticacid, monopotassium salt, L- (8CI);L-Aspartic acid, monopotassium salt (9CI);Aspartic acid monopotassium salt;Monopotassium aspartate;Potassiumaspartate;Potassium hydrogen aspartate; | ||
EINECS: | 214-226-4 | ||
Density: | g/cm3 | ||
Melting Point: | 270-271oC | ||
Boiling Point: | °Cat760mmHg | ||
Flash Point: | °C | ||
Safety: |
|
||
PSA: | 103.45000 | ||
LogP: | -1.76140 |
Conditions | Yield |
---|---|
With potassium hydroxide In water Ambient temperature; | 100% |
potassium hydrogen L-aspartate
Potassium; 3-carboxy-3-oxo-propionate
Conditions | Yield |
---|---|
With potassium hydroxide; 3-{[tris(hydroxymethyl)methyl]amino}propanesulfonic acid; potassium chloride; R292D mutant aspartate aminotransferase In water at 25℃; Equilibrium constant; |
What can I do for you?
Get Best Price
The L-Aspartic acid potassium salt, with the CAS registry number 1115-63-5.It belongs to the product Pharmaceutical Intermediates .Its EINECS number is 214-226-4. This chemical's molecular formula is C4H5KNO4 and molecular weight is 170.18. What's more, Its systematic name is Potassium hydrogen aspartate.And it should Store desiccated in air-tight containers. Physical properties about L-Aspartic acid potassium salt are: (1)#H bond acceptors: 5; (2)#H bond donors: 4; (3)#Freely Rotating Bonds: 4.
You can still convert the following datas into molecular structure:
(1)SMILES:[K+].[O-]C(=O)CC(N)C([O-])=O;
(2)Std. InChI:InChI=1S/C4H7NO4.K/c5-2(4(8)9)1-3(6)7;/h2H,1,5H2,(H,6,7)(H,8,9);/q;+1/p-2;
(3)Std. InChIKey:TXXVQZSTAVIHFD-UHFFFAOYSA-L;
The toxicity data of L-Aspartic acid potassium salt as follows:
Organism | Test Type | Route | Reported Dose (Normalized Dose) | Effect | Source |
---|---|---|---|---|---|
mouse | LD50 | intraperitoneal | 1270mg/kg (1270mg/kg) | Gekkan Yakuji. Pharmaceuticals Monthly. Vol. 9, Pg. 759, 1967. | |
mouse | LD50 | intravenous | 273mg/kg (273mg/kg) | Gekkan Yakuji. Pharmaceuticals Monthly. Vol. 9, Pg. 759, 1967. | |
mouse | LD50 | oral | > 2gm/kg (2000mg/kg) | Gekkan Yakuji. Pharmaceuticals Monthly. Vol. 9, Pg. 759, 1967. | |
mouse | LD50 | subcutaneous | > 2gm/kg (2000mg/kg) | Gekkan Yakuji. Pharmaceuticals Monthly. Vol. 9, Pg. 759, 1967. |